tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ResMed price target raised to $300 from $294 at RBC Capital
PremiumThe FlyResMed price target raised to $300 from $294 at RBC Capital
12d ago
ResMed price target raised to $290 from $270 at Mizuho
Premium
The Fly
ResMed price target raised to $290 from $270 at Mizuho
12d ago
ResMed price target raised to $270 from $240 at Stifel
Premium
The Fly
ResMed price target raised to $270 from $240 at Stifel
12d ago
ResMed price target raised to $298 from $274 at KeyBanc
PremiumThe FlyResMed price target raised to $298 from $274 at KeyBanc
12d ago
ResMed’s Strong Q4 Performance and Strategic Initiatives Drive Buy Rating
Premium
Ratings
ResMed’s Strong Q4 Performance and Strategic Initiatives Drive Buy Rating
12d ago
ResMed reports Q4 EPS $2.55, consensus $2.48
Premium
The Fly
ResMed reports Q4 EPS $2.55, consensus $2.48
13d ago
ResMed upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyResMed upgraded to Outperform from Sector Perform at RBC Capital
28d ago
ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan
Premium
Company Announcements
ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan
1M ago
ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144
Premium
Company Announcements
ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100